The SJD program at Boston College Law School is a highly selective program for students from around the world who are motivated to pursue careers in the academy, research, policy-making, and ...

US-based biopharmaceutical company Cullinan Therapeutics is due to begin a domestic trial of its drug candidate CLN-978 for ...

Johnson & Johnson's FcRn inhibitor nipocalimab has been awarded fast-track status by the FDA as a treatment for Sjögren's disease (SjD), an autoimmune condition that affects millions of people ...

SjD and CLE. “I want to extend my deepest thanks to Pete Salzmann for his leadership of the company through a period of significant growth and transformation. Under Pete, Immunovant has shown ...

Background To investigate whether certain dry eye (DE) metrics relate to oral and pain manifestations of Sjögren’s disease ...